Definition
ATC code R07 is the designation within the Anatomical Therapeutic Chemical (ATC) Classification System for drugs classified as “cough and cold preparations.” It groups medicinal products used primarily to relieve symptoms of cough, nasal congestion, and related upper respiratory tract conditions.
Overview
The ATC system, maintained by the World Health Organization (WHO), organizes pharmaceutical substances according to the organ or system on which they act and their therapeutic, pharmacological, and chemical properties. The main anatomical group “R” refers to the respiratory system. Within this group, the sub‑group “R07” aggregates medications aimed at treating cough and cold symptoms, irrespective of their specific pharmacological class (e.g., antitussives, expectorants, mucolytics, decongestants).
Etymology/Origin
- ATC: Acronym for Anatomical Therapeutic Chemical, a classification method first introduced by the WHO Collaborating Centre for Drug Statistics Methodology in the 1970s.
- R07: The letter “R” denotes the respiratory system, the first digit “0” indicates a therapeutic subgroup, and the final digit “7” is the specific code assigned to the “cough and cold preparations” category during the systematic expansion of the ATC hierarchy.
Characteristics
| Feature | Description |
|---|---|
| Anatomical main group | R – Respiratory system |
| Therapeutic subgroup | R07 – Cough and cold preparations |
| Typical pharmacological classes included | • Antitussives (e.g., codeine, dextromethorphan) • Expectorants (e.g., guaifenesin) • Mucolytics (e.g., acetylcysteine) • Nasal decongestants (e.g., pseudoephedrine, phenylephrine) • Combination products (e.g., antitussive + decongestant) |
| Formulations | Oral tablets, syrups, lozenges, nasal sprays, inhalations, and topical ointments. |
| Regulatory relevance | The R07 classification is used by regulatory agencies, pharmacovigilance databases, and health‑economic studies to aggregate data on usage, safety, and reimbursement of cough‑and‑cold medicines. |
| Clinical scope | Intended for short‑term symptomatic relief of acute upper respiratory tract infections, allergic rhinitis, and other benign cough‑related conditions. Not typically indicated for chronic respiratory diseases such as asthma or chronic obstructive pulmonary disease (COPD) unless specific components are indicated. |
Related Topics
- ATC Classification System – The broader framework for categorizing all medicinal products.
- ATC code R05 – “Cough suppressants and expectorants” (a more specific therapeutic subgroup within respiratory agents).
- ATC code R01 – “Decongestants and other nasal preparations.”
- World Health Organization (WHO) Collaborating Centre for Drug Statistics Methodology – The institution responsible for maintaining and updating the ATC system.
- Pharmacovigilance – Monitoring and evaluation of adverse drug reactions, frequently reported using ATC codes for systematic analysis.
Note: The ATC classification is periodically revised; the specific substances and subgroup definitions within R07 may change in subsequent updates.